Luye Pharma Group Ltd. (HKG:2186)
Hong Kong
· Delayed Price · Currency is HKD 1.970
+0.020 (1.03%)
May 12, 2025, 4:08 PM HKT
Luye Pharma Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 9, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 7,410 | 8,163 | 14,031 | 12,992 | 12,607 | 11,729 | Upgrade
|
| Market Cap Growth | -41.82% | -41.82% | 8.00% | 3.05% | 7.49% | -38.56% | Upgrade
|
| Enterprise Value | 13,175 | 12,502 | 17,078 | 18,013 | 16,610 | 16,596 | Upgrade
|
| Last Close Price | 1.97 | 2.17 | 3.73 | 3.66 | 3.56 | 3.61 | Upgrade
|
| PE Ratio | 14.76 | 16.26 | 23.91 | 19.00 | - | 13.98 | Upgrade
|
| Forward PE | 12.06 | 8.49 | 17.57 | 17.45 | 8.01 | 6.62 | Upgrade
|
| PS Ratio | 1.15 | 1.26 | 2.07 | 1.92 | 1.98 | 1.78 | Upgrade
|
| PB Ratio | 0.44 | 0.49 | 0.94 | 1.04 | 1.13 | 1.22 | Upgrade
|
| P/TBV Ratio | 0.91 | 1.00 | 1.91 | 2.43 | 3.00 | 3.22 | Upgrade
|
| P/FCF Ratio | - | - | 13.23 | 11.51 | - | 28.99 | Upgrade
|
| P/OCF Ratio | 41.51 | 45.72 | 7.98 | 6.95 | 56.32 | 9.56 | Upgrade
|
| PEG Ratio | - | 1.39 | 1.39 | 1.39 | 1.39 | 0.83 | Upgrade
|
| EV/Sales Ratio | 2.04 | 1.94 | 2.52 | 2.66 | 2.60 | 2.52 | Upgrade
|
| EV/EBITDA Ratio | 6.45 | 6.21 | 9.98 | 11.18 | 14.92 | 9.53 | Upgrade
|
| EV/EBIT Ratio | 10.90 | 10.34 | 17.47 | 20.19 | 37.24 | 14.14 | Upgrade
|
| EV/FCF Ratio | -29.04 | - | 16.10 | 15.96 | - | 41.02 | Upgrade
|
| Debt / Equity Ratio | 0.66 | 0.66 | 0.62 | 0.83 | 1.04 | 1.23 | Upgrade
|
| Debt / EBITDA Ratio | 5.38 | 5.38 | 5.33 | 6.27 | 10.09 | 6.68 | Upgrade
|
| Debt / FCF Ratio | - | - | 8.75 | 9.12 | - | 29.30 | Upgrade
|
| Asset Turnover | 0.22 | 0.22 | 0.25 | 0.26 | 0.24 | 0.28 | Upgrade
|
| Inventory Turnover | 2.32 | 2.32 | 2.42 | 2.42 | 2.66 | 2.52 | Upgrade
|
| Quick Ratio | 1.01 | 1.01 | 1.08 | 0.83 | 1.08 | 1.00 | Upgrade
|
| Current Ratio | 1.24 | 1.24 | 1.32 | 1.14 | 1.42 | 1.38 | Upgrade
|
| Return on Equity (ROE) | 4.41% | 4.41% | 4.39% | 5.79% | -1.68% | 8.26% | Upgrade
|
| Return on Assets (ROA) | 2.58% | 2.58% | 2.23% | 2.11% | 1.05% | 3.09% | Upgrade
|
| Return on Capital (ROIC) | 2.96% | 2.96% | 2.63% | 2.55% | 1.24% | 3.48% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.00% | 6.00% | 5.10% | 5.30% | 2.40% | 7.40% | Upgrade
|
| Earnings Yield | 6.78% | 6.15% | 4.18% | 5.26% | -1.31% | 7.16% | Upgrade
|
| FCF Yield | -6.12% | -5.56% | 7.56% | 8.69% | -3.64% | 3.45% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 24.84% | Upgrade
|
| Buyback Yield / Dilution | -0.89% | -0.89% | -7.11% | -1.03% | -7.87% | 0.85% | Upgrade
|
| Total Shareholder Return | -0.89% | -0.89% | -7.11% | -1.03% | -7.87% | 0.85% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.